Cargando…

Plasma Interleukin-27 (IL-27) Levels Are Not Modulated in Patients with Chronic HIV-1 Infection

OBJECTIVE: IL-27 is an immunomodulatory cytokine with potent anti-HIV properties in PBMCs, CD4+ T cells, macrophages and immature dendritic cells. Previous smaller studies have suggested that HIV-1 infection may alter IL-27 and influence HIV-1 pathogenesis. The aim of this study was to examine the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swaminathan, Sanjay, Hu, Zonghui, Rupert, Adam W., Higgins, Jeanette M., Dewar, Robin L., Stevens, Randy, Chen, Qian, Rehm, Catherine A., Metcalf, Julia A., Baseler, Michael W., Lane, H. Clifford, Imamichi, Tomozumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045808/ https://www.ncbi.nlm.nih.gov/pubmed/24896094 http://dx.doi.org/10.1371/journal.pone.0098989

Ejemplares similares

Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation
por: Swaminathan, Sanjay, et al.
Publicado: (2016)

Editorial: IL-27 in health and disease
por: Imamichi, Tomozumi, et al.
Publicado: (2023)

Interleukin-27-induced HIV-resistant dendritic cells suppress reveres transcription following virus entry in an SPTBN1, Autophagy, and YB-1 independent manner
por: Imamichi, Tomozumi, et al.
Publicado: (2023)

Interleukin-27-induced HIV-resistant dendritic cells suppress reveres transcription following virus entry in an SPTBN1, autophagy, and YB-1 independent manner
por: Imamichi, Tomozumi, et al.
Publicado: (2023)

Profiles of Long Non-Coding RNAs and mRNA Expression in Human Macrophages Regulated by Interleukin-27
por: Hu, Xiaojun, et al.
Publicado: (2019)

IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation
por: Dai, Lue, et al.
Publicado: (2013)

Interleukin-27 Enhances the Potential of Reactive Oxygen Species Generation from Monocyte-derived Macrophages and Dendritic cells by Induction of p47(phox)
por: Sowrirajan, Bharatwaj, et al.
Publicado: (2017)

Interleukin-27 Is a Potent Inhibitor of cis HIV-1 Replication in Monocyte-Derived Dendritic Cells via a Type I Interferon-Independent Pathway
por: Chen, Qian, et al.
Publicado: (2013)

Interleukin-27 promotes autophagy in human serum-induced primary macrophages via an mTOR- and LC3-independent pathway
por: Laverdure, Sylvain, et al.
Publicado: (2021)

Genome-Wide Analyses of MicroRNA Profiling in Interleukin-27 Treated Monocyte-Derived Human Dendritic Cells Using Deep Sequencing: A Pilot Study
por: Hu, Xiaojun, et al.
Publicado: (2017)

Profiles of MicroRNAs in Interleukin–27-Induced HIV-Resistant T Cells: Identification of a Novel Antiviral MicroRNA
por: Goswami, Suranjana, et al.
Publicado: (2021)

The effects of storage temperature on PBMC gene expression
por: Yang, Jun, et al.
Publicado: (2016)

IL-27 posttranslationally regulates Y-box binding protein-1 to inhibit HIV-1 replication in human CD4(+) T cells
por: Poudyal, Deepak, et al.
Publicado: (2019)

A novel microRNA, hsa-miR-6852 differentially regulated by Interleukin-27 induces necrosis in cervical cancer cells by downregulating the FoxM1 expression
por: Poudyal, Deepak, et al.
Publicado: (2018)

Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
por: Ruiz-Riol, M., et al.
Publicado: (2017)

Correction: Hu et al. Profiles of Long Non-Coding RNAs and mRNA Expression in Human Macrophages Regulated by Interleukin-27. Int. J. Mol. Sci. 2019, 20, 6207
por: Hu, Xiaojun, et al.
Publicado: (2021)

MicroRNA Profiles in Monocyte-Derived Macrophages Generated by Interleukin-27 and Human Serum: Identification of a Novel HIV-Inhibiting and Autophagy-Inducing MicroRNA
por: Imamichi, Tomozumi, et al.
Publicado: (2021)

Identification of the correlations between interleukin-27 (IL-27) and immune-inflammatory imbalance in preterm birth
por: Ran, Yuxin, et al.
Publicado: (2021)

Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohorts
por: Sherman, Brad T., et al.
Publicado: (2021)

HIV-1 Treated Patients with Undetectable Viral Loads have Lower Levels of Innate Immune Responses via Cytosolic DNA Sensing Systems Compared with Healthy Uninfected Controls
por: Swaminathan, Sanjay, et al.
Publicado: (2014)

Interleukin-27 in T Cell Immunity
por: Iwasaki, Yukiko, et al.
Publicado: (2015)

Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes
por: Petes, Carlene, et al.
Publicado: (2018)

Defective HIV-1 proviruses produce viral proteins
por: Imamichi, Hiromi, et al.
Publicado: (2020)

siRNA enhances DNA-mediated interferon lambda-1 response through crosstalk between RIG-I and IFI16 signalling pathway
por: Sui, Hongyan, et al.
Publicado: (2014)

Associations of IL-27 Polymorphisms and Serum IL-27p28 Levels With Osteosarcoma Risk
por: Tang, Yu-jin, et al.
Publicado: (2014)

Contribution of activated platelets to plasma IL-27 levels
por: Hamzeh-Cognasse, Hind, et al.
Publicado: (2013)

Plasma interleukin-27 levels in patients with coronary artery disease
por: Miura, Kotaro, et al.
Publicado: (2017)

2516. Persistence of Anti-HIV Antibodies in HIV-1-infected Patients on Combination Antiretroviral Therapy (cART) with Prolonged Viral Suppression
por: Singh, Kanal, et al.
Publicado: (2019)

The antitumor potential of Interleukin-27 in prostate cancer
por: Di Carlo, Emma, et al.
Publicado: (2013)

Interleukin-27 levels in patients with myasthenia gravis
por: Liu, Xiao-Jiao, et al.
Publicado: (2020)

Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy
por: Singh, Kanal, et al.
Publicado: (2023)

Potential clinical application of interleukin-27 as an antitumor agent
por: Yoshimoto, Takayuki, et al.
Publicado: (2015)

Immune Regulation of Interleukin-27 in Malignant Pleural Effusion
por: Li, Shi, et al.
Publicado: (2015)

Decreased levels of interleukin 27 in the serum of vitiligo patients()()
por: Hosseini, Saeed Malek, et al.
Publicado: (2020)

Interleukin-27 in Tuberculosis: A Sheep in Wolf’s Clothing?
por: Ritter, Kristina, et al.
Publicado: (2022)

Interleukin-27 and Its Diverse Effects on Bacterial Infections
por: Morita, Yugo, et al.
Publicado: (2021)

Antiviral Activities of Interleukin-27: A Partner for Interferons?
por: Amsden, Heather, et al.
Publicado: (2022)

Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
por: Fernandez Botana, Iria, et al.
Publicado: (2023)

Antiviral response and immunopathogenesis of interleukin 27 in COVID-19
por: Valdés-López, Juan Felipe, et al.
Publicado: (2023)

The IL‐27/IL‐27R axis is altered in CD4(+) and CD8(+) T lymphocytes from multiple sclerosis patients
por: Clénet, Marie‐Laure, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6n88n0afqlermp907mv2cqet4